Weight-loss jabs could improve liver health by reducing inflammation and scarring even without significant weight loss, a new study has found.
Researchers at Toronto's Sinai Health have found that semaglutide, the active ingredient in popular weight-loss drugs that mimic the gut hormone GLP-1, can act directly on a type of liver cell.